US 9206172
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted A61KA61K31/439A61K31/46
Quick answer
US patent 9206172 (8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/439, A61K31/46, A61K31/485, A61K45/06